Indresh Kaur
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Polyomavirus and related diseases, Hematopoietic Stem Cell Transplantation, Immune Cell Function and Interaction, Parvovirus B19 Infection Studies
Most-Cited Works
- → Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors(2020)2,047 cited
- → Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation(2021)63 cited
- → A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy(2016)53 cited
- → Low rate of infusional toxicity after expanded cord blood transplantation(2014)13 cited
- → Evidence for the role of histaminergic pathways in neuroprotective mechanism of ischemic postconditioning in mice(2017)11 cited
- → Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma(2023)6 cited
- → Role of BK Virus CTLs in the Treatment of BK Virus–Associated Nephropathy in Kidney‐Transplant and Hematopoietic Cell Transplant Recipients(2026)
- → DCVax®- DIRECT: autologous activated dendritic cells for image guided intra-tumoral vaccination in patients with solid tumors - a phase I/II clinical trial in progress(2013)
- → Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment(2025)